caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1861657785

Tabraiz Mohammed

PRACTICEMEDCENTRIX INCSee all providers at this practice →
Hematology-OncologyChicago, ILI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
991
Unique beneficiaries
—
Total services
2,303
Distinct HCPCS
12
Medicare payment
$152K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 444 Hematology-Oncology providers in IL — above median (cohort median 1,266).
REFERRAL NETWORK

Where Tabraiz Mohammed's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
TRIPP, WARREN1821
STOUGHTON HOSPITAL ASSOCIATION1414
Peter Stier
Emergency Medicine · Madison, WI
1112
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,418
Beneficiaries
—
Total drug cost
$2.6M
Distinct drugs
39
Brand share
31.8%
Top prescribed drugs
Anastrozole156 claims
Apixaban128 claims
Prochlorperazine Maleate100 claims
Acyclovir98 claims
Ondansetron Hcl87 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.